Zanella, Ilaria
 Distribuzione geografica
Continente #
NA - Nord America 605
EU - Europa 146
AS - Asia 85
OC - Oceania 6
SA - Sud America 2
Totale 844
Nazione #
US - Stati Uniti d'America 600
IT - Italia 63
SG - Singapore 26
VN - Vietnam 24
FI - Finlandia 17
SE - Svezia 16
CN - Cina 14
GB - Regno Unito 12
DE - Germania 10
ID - Indonesia 10
FR - Francia 8
AU - Australia 6
CZ - Repubblica Ceca 6
CA - Canada 5
IL - Israele 4
BG - Bulgaria 3
BE - Belgio 2
BR - Brasile 2
IR - Iran 2
PL - Polonia 2
RO - Romania 2
AT - Austria 1
CH - Svizzera 1
DK - Danimarca 1
ES - Italia 1
IN - India 1
JO - Giordania 1
JP - Giappone 1
KG - Kirghizistan 1
NL - Olanda 1
TW - Taiwan 1
Totale 844
Città #
Fairfield 98
Chandler 83
Ashburn 50
Seattle 43
Woodbridge 40
Cambridge 39
Houston 35
New York 22
Wilmington 21
Dong Ket 18
Singapore 18
Helsinki 16
Princeton 16
Ann Arbor 15
Como 15
San Mateo 14
Jakarta 10
Trento 9
Los Angeles 7
Brno 6
Fremont 6
San Diego 6
Sydney 6
London 5
Parma 5
Augusta 4
Cagliari 4
Toronto 4
Bolzano 3
Pontassieve 3
Sofia 3
Andover 2
Boardman 2
Bremen 2
Centro 2
Cernusco sul Naviglio 2
Comabbio 2
Dallas 2
Lagundo 2
Lamezia Terme 2
Munich 2
Norwalk 2
Phoenix 2
Pisa 2
Qiryat Ata 2
Riva Del Garda 2
Stockholm 2
São Paulo 2
Bassano del Grappa 1
Beijing 1
Bishkek 1
Bonndorf 1
Bristol 1
Brussels 1
Chicago 1
Clearwater 1
Dearborn 1
Fort Worth 1
Gent 1
Jacksonville 1
Miami Beach 1
Milan 1
Ottawa 1
Paris 1
Pune 1
Redmond 1
Rishon LeTsiyyon 1
Rome 1
Sabz 1
San Paolo di Civitate 1
Santa Clara 1
Taipei 1
Tel Aviv 1
Tokyo 1
Turin 1
Vienna 1
Warsaw 1
Washington 1
Totale 688
Nome #
Vaccination with a FAT1-derived B cell epitope combined with tumor-specific B and T cell epitopes elicits additive protection in cancer mouse models 144
Some Gram-negative lipoproteins keep their surface topology when transplanted from one species to another and deliver foreign polypeptides to the bacterial surface 124
Bacterial outer membrane vesicles engineered with lipidated antigens as a platform for Staphylococcus aureus vaccine 114
Synergistic protective activity of tumor-specific epitopes engineered in bacterial outer membrane vesicles 101
VSV-G-Enveloped Vesicles for Traceless Delivery of CRISPR-Cas9 87
Large scale validation of an efficient CRISPR/Cas-based multi gene editing protocol in Escherichia coli 85
Proteome-minimized outer membrane vesicles from Escherichia coli as a generalized vaccine platform 72
Multiple Stepwise Gene Knockout Using CRISPR/Cas9 in Escherichia coli 64
Commensal Bifidobacterium Strains Enhance the Efficacy of Neo-Epitope Based Cancer Vaccines 27
Construction and characterization of proteome-minimized OMVs from E. coli and their exploitation in infectious disease and cancer vaccines 26
Anti-Tumor Efficacy of In Situ Vaccination Using Bacterial Outer Membrane Vesicles 12
Immunogenicity and Pre-Clinical Efficacy of an OMV-Based SARS-CoV-2 Vaccine 12
Outer Membrane Vesicles From The Gut Microbiome Contribute to Tumor Immunity by Eliciting Cross-Reactive T Cells 10
Totale 878
Categoria #
all - tutte 5.226
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.226


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202031 0 0 0 2 2 4 4 4 6 4 2 3
2020/2021340 2 4 2 90 16 53 44 17 10 26 40 36
2021/2022130 9 7 2 6 9 9 5 19 12 15 12 25
2022/2023173 30 17 13 29 5 21 2 13 16 1 12 14
2023/2024106 5 3 5 2 6 31 6 12 2 12 3 19
2024/202588 8 3 41 36 0 0 0 0 0 0 0 0
Totale 878